ABEONA THERAPEUTICS INC.— Sankey Diagram
Annual mode · period ending 2025-12-31 · SEC EDGAR
FY2025 - Q4(Oct 25 · Nov 25 · Dec 25)
Total Assets
$220M
↑+101.6% +$111Mvs FY2024
Total Liabilities
$60M
↓-7.0% -$5Mvs FY2024
Equity
$159M
↑+261.6% +$115Mvs FY2024
Cash
$78M
↑+235.8% +$55Mvs FY2024
Click a Metric or Sankey Node to View Historical Trends
Show Source Data (Audit Panel)
| Line item | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $220M | $109M |
| Current Assets | $205M | $101M |
| Cash | $78M | $23M |
| ST Investments | $113M | $74M |
| Receivables | $6M | $0 |
| Inventory | $5M | $0 |
| Other Current | $2M | $3M |
| Non-Current Assets | $15M | $8M |
| PPE | $10M | $4M |
| Goodwill | $0 | $0 |
| Intangibles | $0 | $0 |
| Investments | $0 | $0 |
| Other Non-Current | $5M | $4M |
| Total Liab+Eq | $220M | $109M |
| Current Liab. | $30M | $17M |
| Accounts Payable | $8M | $3M |
| Short-Term Debt | $0 | $0 |
| Deferred Revenue | $0 | $0 |
| Other CL | $22M | $13M |
| Non-Current Liab. | $31M | $48M |
| Long-Term Debt | $20M | $19M |
| Other LT Liab. | $11M | $29M |
| Equity | $159M | $44M |
| Retained Earnings | $742M | $813M |
| Other Equity | $0 | $0 |
QuarterCharts · SEC EDGAR data · ABEO · Comparing FY2025 vs FY2024